SCHEMBL26885359

SCHEMBL26885359

CC(C)NC(=O)c1cccc2cccc(S(=O)(=O)O)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.48
▸ TTR P02766 1/20 0.44
▸ FABP4 P15090 1/20 0.44
▸ CCNA2 P20248 1/20 0.44
▸ CDK2 P24941 1/20 0.44
▸ MAPK14 Q16539 1/20 0.44
▸ NR4A1 P22736 1/20 0.43
▸ CD40 P25942 1/20 0.43
▸ CD40LG P29965 1/20 0.43
▸ MAOA P21397 1/20 0.42
▸ MAOB P27338 1/20 0.42
▸ MEN1 O00255 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ KCNA5 P22460 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26885060 0.85 LMNA (0.41) LMNAMAOAMAOBMEN1POLB
SCHEMBL26885782 0.85 LMNA (0.41) LMNAMAOAMAOBMEN1POLB
SCHEMBL26885356 0.78 HSD17B10 (0.53) LMNANR4A1MAOAMAOBMEN1
SCHEMBL26885157 0.78 KDM4E (0.49) LMNAMAOAMAOBPOLBALDH1A1
SCHEMBL26885054 0.78 MAOA (0.46) LMNAMAOAMAOBALDH1A1PKM
SCHEMBL26887046 0.77 KDM4E (0.46) LMNAMAOAMAOBMEN1POLB
SCHEMBL26885809 0.77 APEX1 (0.46) LMNAMAOAMAOBALDH1A1TSHR
SCHEMBL2872513 0.76 TTR (0.46) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL26888728 0.76 ERN1 (0.47) LMNACD40CD40LGMEN1KMT2A
SCHEMBL26885787 0.76 CASP6 (0.54) LMNAMAOAMAOBPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381159-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF UNIVERSITY OF MIAMI 2023-11-30 — — US disclosed
US-20230381159-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF UNIVERSITY OF MIAMI 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381159-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF ACE2, ACE, SARS1 LMNA 2523/4885TTR 2451/4885FABP4 1655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback